CDK 4/6 Inhibitors in HR+/HER2- Breast Cancer – Huntington, WV
Marshall University Pediatrics Cabell Huntington Hospital 1340 Hal Greeg Blvd, HuntingtonThis program will review the use of CDK 4/6 inhibitors in the treatment of HR+/HER2-negative breast cancer and the management of treatment-related adverse events.